Image

Evaluation of Mechanical Power and Ventilator Parameters to Predict Weaning Success in the Intensive Care Unit

Evaluation of Mechanical Power and Ventilator Parameters to Predict Weaning Success in the Intensive Care Unit

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this prospective observational study is to evaluate whether ventilator-based respiratory parameters can predict weaning success in adult intensive care unit (ICU) patients who are mechanically ventilated. The main questions it aims to answer are:

Can the mechanical power (MP) value predict successful extubation? Do other respiratory parameters-airway occlusion pressure (P0.1), negative inspiratory force (NIF), and the rapid shallow breathing index (RSBI)-provide additional prognostic value for weaning outcomes?

Participants will:

  • Be adult ICU patients planned for weaning from mechanical ventilation.
  • Undergo bedside ventilatory assessment within 2 hours after meeting clinical weaning criteria.
  • Have the following respiratory parameters measured: MP, P0.1, NIF, and RSBI.
  • Be monitored for 48 hours after extubation to assess weaning success (defined as no need for reintubation, non-invasive ventilation, or high-flow oxygen support)

Description

This is a prospective, observational, single-center study designed to investigate whether ventilator-derived physiological measurements can predict weaning success in mechanically ventilated adult ICU patients. The primary objective is to determine the prognostic value of mechanical power (MP) in forecasting successful extubation.

Secondary objectives include the evaluation of additional respiratory parameters such as airway occlusion pressure (P0.1), negative inspiratory force (NIF), the rapid shallow breathing index (RSBI), and the mechanical power/negative inspiratory force ratio (MP/NIF). These parameters will be measured at the bedside within 2 hours after patients meet clinical weaning criteria and are hemodynamically stable.

All participants will be monitored for 48 hours after extubation. Weaning success is defined as the ability to sustain spontaneous breathing without the need for reintubation, non-invasive ventilation, or high-flow oxygen therapy during this period.

Data collection will include:

Respiratory measurements obtained from the ventilator: MP, P0.1, NIF, RSBI, and MP/NIF.

Demographic and clinical data: age, sex, BMI, ICU admission diagnosis, APACHE II and SOFA scores, ventilator settings, and duration of mechanical ventilation.

Post-extubation follow-up: reintubation, non-invasive ventilation or high-flow oxygen use, SpO₂ values, blood gas analysis, and vital signs.

This study does not involve any interventions beyond standard ICU care. Ventilator-based respiratory assessments are routinely performed in ICU settings and pose no additional risk to participants.

The results may support the integration of load-drive-capacity assessment into routine ICU weaning protocols and improve clinical decision-making by reducing the incidence of weaning failure and associated complications.

Eligibility

Inclusion Criteria:

\-

Age ≥ 18 years (adult patient population)

  • Patients receiving invasive mechanical ventilation in the intensive care unit
  • Having been intubated for at least 24 hours
  • Patients for whom the clinical team has decided extubation and who meet the following weaning criteria:
  • Stable respiratory parameters (FiO₂ ≤ 40%, PEEP ≤ 5 cmH₂O, SpO₂ ≥ 92%)
  • Hemodynamic stability (no inotropic support or minimal/stable dose)
  • Appropriate neurological status (able to follow commands)
  • Stable acid-base balance
  • Adequate secretion control
  • Technically suitable ventilator and measurement conditions
  • Written informed consent obtained from the patient or legal representative

Exclusion Criteria:

  • Patients with any of the following conditions will be excluded:

and

  • Individuals under 18 years of age
  • Pregnant patients
  • Patients who do not meet the weaning criteria
  • Tracheostomized patients
  • Neuromuscular diseases (e.g., Guillain-Barré syndrome, Duchenne muscular dystrophy, etc.)
  • Technical inadequacy preventing correct ventilator measurements
  • Significant asynchrony (e.g., auto-PEEP, double triggering, ineffective triggering, cycle asynchrony, auto-triggering)
  • Patients without an extubation plan or those receiving palliative care
  • RASS ≤ -2 (excessive sedation) for PSV mode measurements
  • RASS ≥ +2 (agitation) for PSV-CPAP mode measurements
  • Patients with delirium for PSV-CPAP mode measurements
  • Patients who cannot provide consent, have no legal representative, or whose representative refuses consent

Study details
    Weaning Mechanical Ventilation
    Mechanical Power
    Negative Inspiratory Force
    Airway Occlusion Pressure

NCT07268989

Anıl Berkay Balıtatlı

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.